相关实验视频
Updated: Jul 20, 2026

11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
一个家庭因AKT2突变而患有严重的胰岛素抵抗和糖尿病
Stella George1, Justin J Rochford, Christian Wolfrum
1Department of Clinical Biochemistry, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK.
概括
在AKT2基因的突变导致严重的胰岛素抵抗和糖尿病. 这项研究强调了AKT信号在人类胰岛素敏感性中的关键作用,影响了2型糖尿病的发展.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
背景情况:
- 胰岛素抵抗是2型糖尿病的一个关键因素.
- 胰岛素受体下游的信号通路与糖尿病病原发生有关.
- 蛋白激酶AKT2 (也称为PKBbeta) 在胰岛素信号传递中发挥作用.
研究的目的:
- 调查胰岛素受体信号通路在2型糖尿病中遗传缺陷的作用.
- 确定导致严重胰岛素抵抗和糖尿病的特定遗传突变.
- 阐明AKT2/PKBbeta蛋白激酶在人类胰岛素敏感性中的功能.
主要方法:
- 一个家族具有严重胰岛素抵抗和糖尿病的自体主导遗传的遗传分析.
- 分子克隆和突变AKT2/PKBbeta激酶在培养细胞中的表达.
- 评估胰岛素信号干扰和对野生类型AKT功能的影响.
主要成果:
- 在一个家族中发现了AKT2/PKBbeta基因的突变,该家族具有自身主导的严重胰岛素耐药性和糖尿病.
- 在培养细胞中突变AKT2激酶的表达会损害对代谢点的胰岛素信号传递.
- 突变的AKT2激酶抑制了同表达的野生型AKT的功能,这表明了主导负面效应.
结论:
- 在AKT信号传递中遗传的缺陷是人类2型糖尿病的重要原因.
- AKT2/PKBbeta的突变可以通过破坏胰岛素信号传递导致严重的胰岛素抵抗和糖尿病.
- AKT信号传递对于维持人类胰岛素敏感性至关重要.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

